Hofseth BioCare ASA (OSL:HBC)
Norway · Delayed Price · Currency is NOK 1.100
+0.015 (1.38%)
Nov 4, 2026, 12:02 PM CET
Hofseth BioCare ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Operating Revenue | 63.09 | 48.79 | 71.14 | 54.8 | 67.77 | 60.72 | 64.93 | 67.61 | 72.19 | 52.1 | 45.89 | 49.62 | 50.77 | 44.53 | 33.85 | 29.79 | 25.28 | 30.22 | 15.45 | 13.66 |
Other Revenue | 2.6 | 0.69 | 1.01 | 0.09 | 0.67 | 0.14 | -0.04 | 0.27 | 8.22 | 0.26 | 1.54 | 0.26 | 25.66 | 0.24 | -0.24 | 0.44 | 0.56 | 0.57 | 10.63 | - |
| 65.69 | 49.48 | 72.15 | 54.89 | 68.44 | 60.86 | 64.89 | 67.89 | 80.41 | 52.36 | 47.43 | 49.89 | 76.43 | 44.77 | 33.61 | 30.22 | 25.83 | 30.78 | 26.08 | 13.66 | |
Revenue Growth (YoY) | -4.02% | -18.71% | 11.20% | -19.15% | -14.88% | 16.24% | 36.82% | 36.08% | 5.21% | 16.95% | 41.11% | 65.06% | 195.85% | 45.43% | 28.87% | 121.29% | -16.78% | 82.85% | 13.13% | 80.22% |
Cost of Revenue | 34.63 | 29.31 | 69.1 | 35.38 | 35.75 | 37.47 | 65.83 | 49.01 | 47.62 | 27.35 | 63.74 | 32.86 | 27.08 | 41.31 | 38.18 | 24.48 | 17.74 | 22.09 | 33.48 | 13.62 |
Gross Profit | 31.06 | 20.17 | 3.05 | 19.51 | 32.7 | 23.4 | -0.95 | 18.87 | 32.79 | 25.01 | -16.32 | 17.02 | 49.35 | 3.46 | -4.57 | 5.74 | 8.09 | 8.7 | -7.4 | 0.04 |
Selling, General & Admin | 16.87 | 22.62 | 46.06 | 21.63 | 14.38 | 20.22 | 42.6 | 19.31 | 12.12 | 17.34 | 35.47 | 15.51 | 10.88 | 14.4 | 37.36 | 14.63 | 9.26 | 14.79 | 27.69 | 11.96 |
Other Operating Expenses | 16.85 | 20.72 | -16.44 | 18.99 | 23.69 | 20.08 | -17.46 | 20.58 | 22.65 | 23.9 | -12 | 17.68 | 20.14 | 17.56 | -13.66 | 16.52 | 17.17 | 20.11 | -8.49 | 17.33 |
Operating Expenses | 43.94 | 53.78 | 40.4 | 50.11 | 47.55 | 49.86 | 35.82 | 49.42 | 44.36 | 51.22 | 32.96 | 42.19 | 40.97 | 39.92 | 30.49 | 38.86 | 34.88 | 42.16 | 26.6 | 36.79 |
Operating Income | -12.88 | -33.61 | -37.35 | -30.6 | -14.86 | -26.47 | -36.76 | -30.54 | -11.57 | -26.21 | -49.28 | -25.17 | 8.38 | -36.46 | -35.06 | -33.11 | -26.79 | -33.47 | -34.01 | -36.75 |
Interest Expense | -7.66 | -7.23 | -6.83 | -5.93 | -5.96 | -4.11 | -4.63 | -4.14 | -3.64 | -3.28 | -0.43 | -2.24 | -2.58 | -2.3 | -2.84 | -2.14 | -2.88 | -2.09 | -4.34 | -1.24 |
Interest & Investment Income | 0.11 | 0.24 | 0.94 | 0.48 | 0.57 | 0.01 | 0.77 | 0.01 | 0.01 | 0 | 0.55 | 0 | 1.78 | - | 0.56 | 0.09 | 0 | - | 0.6 | - |
Earnings From Equity Investments | -2.39 | -1 | -3.38 | 7.09 | -0.77 | -0.78 | -3.83 | -1.01 | -1.83 | -0.81 | -2.49 | 5.03 | - | - | -0.2 | - | - | - | 0.03 | - |
Currency Exchange Gain (Loss) | -0.39 | 5.03 | -1.61 | 0.65 | -3.98 | 1.27 | 0.73 | 0.68 | -0.54 | 1.29 | -0.25 | -0.34 | -0.03 | 0.92 | -0.54 | 0.1 | 1.29 | -0.11 | 0.52 | 0.2 |
Other Non Operating Income (Expenses) | - | - | 0.05 | - | - | - | -0 | 0 | 0 | - | -0 | 0 | -1.79 | - | 0.05 | 0 | -0 | - | -0 | - |
EBT Excluding Unusual Items | -23.21 | -36.57 | -48.18 | -28.31 | -25 | -30.09 | -43.72 | -35.01 | -17.56 | -29.01 | -51.9 | -22.72 | 5.76 | -37.84 | -38.04 | -35.07 | -28.38 | -35.67 | -37.19 | -37.79 |
Merger & Restructuring Charges | - | - | - | - | - | -3.03 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Asset Writedown | - | - | -0.09 | - | - | - | - | - | - | - | - | - | - | - | -0.19 | - | - | - | - | - |
Pretax Income | -23.21 | -36.57 | -48.28 | -28.31 | -25 | -33.12 | -43.72 | -35.01 | -17.56 | -29.01 | -51.9 | -22.72 | 5.76 | -37.84 | -38.22 | -35.07 | -28.38 | -35.67 | -37.19 | -37.79 |
Income Tax Expense | 0.18 | - | - | - | 0.18 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings From Continuing Operations | -23.4 | -36.57 | -48.28 | -28.31 | -25.18 | -33.12 | -43.72 | -35.01 | -17.56 | -29.01 | -51.9 | -22.72 | 5.76 | -37.84 | -38.22 | -35.07 | -28.38 | -35.67 | -37.19 | -37.79 |
Minority Interest in Earnings | - | 0 | - | - | - | 0 | 0 | - | - | - | - | - | 0 | - | 0 | - | - | - | 0 | - |
Net Income | -23.4 | -36.57 | -48.28 | -28.31 | -25.18 | -33.12 | -43.72 | -35.01 | -17.56 | -29.01 | -51.9 | -22.72 | 5.76 | -37.84 | -38.22 | -35.07 | -28.38 | -35.67 | -37.19 | -37.79 |
Net Income to Common | -23.4 | -36.57 | -48.28 | -28.31 | -25.18 | -33.12 | -43.72 | -35.01 | -17.56 | -29.01 | -51.9 | -22.72 | 5.76 | -37.84 | -38.22 | -35.07 | -28.38 | -35.67 | -37.19 | -37.79 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 411 | 411 | 411 | 411 | 411 | 411 | 411 | 411 | 411 | 410 | 395 | 395 | 395 | 395 | 395 | 388 | 358 | 358 | 358 | 358 |
Shares Outstanding (Diluted) | 426 | 426 | 411 | 412 | 412 | 412 | 412 | 411 | 412 | 412 | 396 | 396 | 396 | 396 | 396 | 393 | 363 | 363 | 358 | 358 |
Shares Change (YoY) | 3.40% | 3.40% | -0.24% | 0.24% | -0.04% | 0.13% | 3.99% | 3.74% | 4.04% | 3.86% | 0.04% | 0.75% | 9.05% | 9.05% | 10.69% | 9.92% | - | 1.54% | 1.30% | 6.88% |
EPS (Basic) | -0.06 | -0.09 | -0.12 | -0.07 | -0.06 | -0.08 | -0.11 | -0.09 | -0.04 | -0.07 | -0.13 | -0.06 | 0.01 | -0.10 | -0.10 | -0.09 | -0.08 | -0.10 | -0.10 | -0.11 |
EPS (Diluted) | -0.06 | -0.09 | -0.12 | -0.07 | -0.06 | -0.08 | -0.11 | -0.09 | -0.04 | -0.07 | -0.13 | -0.06 | 0.01 | -0.10 | -0.10 | -0.09 | -0.08 | -0.10 | -0.10 | -0.11 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -5.36 | -24.61 | 5.58 | -3.06 | -35.25 | -15.39 | 20.13 | -13.33 | 0.47 | -21.12 | -12.73 | 6.98 | 1.82 | -1.51 | 47.72 | -40.37 | -44.14 | -12.4 | -21.31 | -21.43 |
Free Cash Flow Per Share | -0.01 | -0.06 | 0.01 | -0.01 | -0.09 | -0.04 | 0.05 | -0.03 | 0.00 | -0.05 | -0.03 | 0.02 | 0.01 | -0.00 | 0.12 | -0.10 | -0.12 | -0.03 | -0.06 | -0.06 |
Gross Margin | 47.28% | 40.77% | 4.23% | 35.54% | 47.77% | 38.44% | -1.46% | 27.80% | 40.78% | 47.77% | -34.41% | 34.12% | 64.56% | 7.73% | -13.61% | 19.01% | 31.33% | 28.25% | -28.38% | 0.30% |
Operating Margin | -19.60% | -67.93% | -51.76% | -55.76% | -21.71% | -43.49% | -56.66% | -44.99% | -14.39% | -50.06% | -103.91% | -50.45% | 10.96% | -81.44% | -104.33% | -109.56% | -103.69% | -108.72% | -130.39% | -269.12% |
Profit Margin | -35.61% | -73.91% | -66.91% | -51.58% | -36.79% | -54.41% | -67.38% | -51.57% | -21.84% | -55.40% | -109.43% | -45.53% | 7.54% | -84.52% | -113.73% | -116.03% | -109.87% | -115.86% | -142.60% | -276.72% |
Free Cash Flow Margin | -8.15% | -49.74% | 7.74% | -5.57% | -51.50% | -25.29% | 31.02% | -19.63% | 0.59% | -40.33% | -26.83% | 13.99% | 2.38% | -3.36% | 141.98% | -133.57% | -170.84% | -40.29% | -81.69% | -156.89% |
EBITDA | -8.76 | -27.01 | -33.63 | -27.12 | -5.37 | -16.91 | -32.05 | -21.02 | -1.98 | -16.23 | -46.77 | -16.16 | 18.33 | -28.5 | -32.72 | -25.4 | -18.33 | -26.21 | -29.08 | -29.25 |
EBITDA Margin | -13.33% | -54.59% | -46.61% | -49.41% | -7.85% | -27.79% | -49.40% | -30.96% | -2.46% | -30.99% | -98.62% | -32.40% | 23.99% | -63.66% | -97.36% | -84.05% | -70.95% | -85.13% | -111.52% | -214.14% |
D&A For EBITDA | 4.12 | 6.6 | 3.72 | 3.49 | 9.48 | 9.56 | 4.71 | 9.53 | 9.59 | 9.98 | 2.51 | 9.01 | 9.96 | 7.96 | 2.34 | 7.71 | 8.46 | 7.26 | 4.92 | 7.51 |
EBIT | -12.88 | -33.61 | -37.35 | -30.6 | -14.86 | -26.47 | -36.76 | -30.54 | -11.57 | -26.21 | -49.28 | -25.17 | 8.38 | -36.46 | -35.06 | -33.11 | -26.79 | -33.47 | -34.01 | -36.75 |
EBIT Margin | -19.60% | -67.93% | -51.76% | -55.76% | -21.71% | -43.49% | -56.66% | -44.99% | -14.39% | -50.06% | -103.91% | -50.45% | 10.96% | -81.44% | -104.33% | -109.56% | -103.69% | -108.72% | -130.39% | -269.12% |
Revenue as Reported | 65.69 | 49.48 | 72.15 | 54.89 | 68.44 | 60.86 | 64.89 | 67.89 | 80.41 | 52.36 | 47.43 | 49.89 | 76.43 | 44.77 | 33.61 | 30.22 | 25.83 | 30.78 | 26.08 | 13.66 |